| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00595-012-0468-2 |
| P8608 | Fatcat ID | release_tgxofxphprbxzlahlhswgal2ae |
| P698 | PubMed publication ID | 23283352 |
| P2093 | author name string | Hiroyuki Kuwano | |
| Minoru Fukuchi | |||
| Takehiko Yokobori | |||
| Hiroyuki Kato | |||
| Masanobu Nakajima | |||
| Tatsuya Miyazaki | |||
| Daigo Ozawa | |||
| Makoto Sohda | |||
| Naritaka Tanaka | |||
| Shigemasa Suzuki | |||
| Takanori Inose | |||
| P2860 | cites work | The oesophagus lined with gastric mucous membrane | Q24515052 |
| Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study | Q24609281 | ||
| Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence | Q28182230 | ||
| Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis | Q28194560 | ||
| Molecular changes in the progression of Barrett's oesophagus | Q28219148 | ||
| Laser and multipolar electrocoagulation ablation of early Barrett's adenocarcinoma: long-term follow-up | Q30670508 | ||
| Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma | Q30985672 | ||
| Endoscopic mucosal resection of Barrett's oesophagus containing dysplasia or intramucosal cancer. | Q33286792 | ||
| p16 mutation spectrum in the premalignant condition Barrett's esophagus | Q33388259 | ||
| Significance of Fas and retinoblastoma protein expression during the progression of Barrett's metaplasia to adenocarcinoma | Q33642981 | ||
| Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. | Q33851569 | ||
| Risk of lymph node metastasis in submucosal esophageal cancer: a review of surgically resected patients. | Q33925951 | ||
| Is there publication bias in the reporting of cancer risk in Barrett's esophagus? | Q33993884 | ||
| The lower esophagus lined by columnar epithelium | Q34241534 | ||
| Chronic peptic ulcer of the oesophagus and 'oesophagitis'. | Q34295930 | ||
| Clinical practice. Barrett's Esophagus | Q34563466 | ||
| Meta analysis: Cancer risk in Barrett's oesophagus. | Q34694561 | ||
| Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus | Q34761782 | ||
| Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus | Q35595358 | ||
| Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. | Q35613515 | ||
| A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. | Q35827411 | ||
| Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis | Q36479652 | ||
| Autofluorescence imaging and narrow-band imaging for the detection of early neoplasia in patients with Barrett's esophagus | Q36520136 | ||
| Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus | Q37019152 | ||
| Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis | Q37702125 | ||
| Still waiting for predictive biomarkers in Barrett's oesophagus. | Q37878719 | ||
| Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison | Q38450063 | ||
| Reflux of duodenal or gastro-duodenal contents induces esophageal carcinoma in rats | Q39255662 | ||
| Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. | Q39379182 | ||
| Long-term outcome of antireflux surgery in patients with Barrett's esophagus | Q39414337 | ||
| Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease | Q39440173 | ||
| Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. | Q39737918 | ||
| Thoracic and cardiovascular surgery in Japan during 2003: annual report by The Japanese Association for Thoracic Surgery | Q40384111 | ||
| Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus | Q40417530 | ||
| Barrett-esophagus Following Total Gastrectomy: A Contribution to it's Pathogenesis | Q41621061 | ||
| New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus | Q41808634 | ||
| Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice | Q42071066 | ||
| Endoscopic submucosal dissection of a minute intramucosal adenocarcinoma in Barrett's esophagus | Q42458684 | ||
| Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus | Q43589311 | ||
| The histologic spectrum of Barrett's esophagus | Q43675586 | ||
| Thoracic and cardiovascular surgery in Japan during 2004. | Q43701553 | ||
| Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans | Q43757853 | ||
| Gastric surgery is not a risk for Barrett's esophagus or esophageal adenocarcinoma | Q43812724 | ||
| Changing patterns in the incidence of esophageal and gastric carcinoma in the United States | Q43873434 | ||
| Long-term outcome of 2920 patients with cancers of the esophagus and esophagogastric junction: evaluation of the New Union Internationale Contre le Cancer/American Joint Cancer Committee staging system | Q44520520 | ||
| Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus | Q44779979 | ||
| AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease | Q44893022 | ||
| Esophageal adenocarcinoma incidence: are we reaching the peak? | Q45001265 | ||
| Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer | Q45166040 | ||
| Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial | Q45172897 | ||
| Thoracic and cardiovascular surgery in Japan during 2006: annual report by the Japanese Association for Thoracic Surgery | Q46744082 | ||
| Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma. | Q47879656 | ||
| Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial. | Q48736100 | ||
| A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett's esophagus. | Q50463490 | ||
| Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus. | Q50512145 | ||
| Management of Barrett's esophagus: a national study of practice patterns and their cost implications. | Q50655092 | ||
| Thoracic and cardiovascular surgery in Japan during 2005. Annual report by the Japanese Association for Thoracic Surgery. | Q51108649 | ||
| Trend in incidence of adenocarcinoma of the esophagus in Japan, 1993-2001. | Q51119971 | ||
| Thoracic and cardiovascular surgery in Japan during 2007. Annual report by the Japanese Association for Thoracic Surgery. | Q51136634 | ||
| Thoracic and cardiovascular surgery in Japan during 2008: annual report by The Japanese Association for Thoracic Surgery. | Q51148305 | ||
| Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. | Q51175652 | ||
| Prague C&M and Japanese criteria: shades of Barrett's esophagus endoscopic diagnosis. | Q51559882 | ||
| Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology. | Q53037874 | ||
| Prediction of Lymph Node Status in Superficial Esophageal Carcinoma | Q56914069 | ||
| Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case–Control Study | Q57259895 | ||
| The Development and Validation of an Endoscopic Grading System for Barrett’s Esophagus: The Prague C & M Criteria | Q58104636 | ||
| Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma | Q58204833 | ||
| Cyclin A Immunocytology as a Risk Stratification Tool for Barrett's Esophagus Surveillance | Q58787923 | ||
| Cost Utility of Screening for Barrett’s Esophagus With Esophageal Capsule Endoscopy Versus Conventional Upper Endoscopy | Q59355454 | ||
| Ducts of esophageal glands proper and paneth cells in Barrett's esophagus: frequency in biopsy specimens | Q71438434 | ||
| Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis | Q72366072 | ||
| p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study | Q72638571 | ||
| Current trends in the surgical treatment of esophageal and cardia adenocarcinoma | Q73292133 | ||
| Practice patterns for surveillance of Barrett's esophagus in the united states | Q74098000 | ||
| Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice | Q74250578 | ||
| Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus | Q74593805 | ||
| Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas | Q77363569 | ||
| Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group | Q77424043 | ||
| Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction | Q78081542 | ||
| Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus | Q78551320 | ||
| [Endoscopic diagnosis of Barrett's esophagus] | Q81062624 | ||
| Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus | Q81226171 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system | Q81508714 | ||
| Islands of squamous epithelium and their surrounding mucosa in columnar-lined esophagus: a pathognomonic feature of Barrett's esophagus? | Q81576884 | ||
| High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas | Q82556447 | ||
| Gastric surgery is not a risk factor for erosive esophagitis or Barrett's esophagus | Q82564049 | ||
| Esophageal adenocarcinoma after Nissen's fundoplication for Barrett's esophagus: report of a case | Q82620221 | ||
| Evaluation of modified crystal violet chromoendoscopy procedure using new mucosal pit pattern classification for detection of Barrett's dysplastic lesions | Q82856609 | ||
| ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract | Q82971241 | ||
| Prognostic influence of immunohistochemically detected lymph node micrometastasis and histological subtype in pN0 oesophageal cancer | Q83143769 | ||
| Utility of autofluorescence imaging videoendoscopy in screening for Barrett's esophagus | Q84100879 | ||
| Prediction model of lymph node metastasis in superficial esophageal adenocarcinoma and squamous cell cancer including D2-40 immunostaining | Q84110852 | ||
| Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma | Q93929890 | ||
| Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus | Q94043002 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 353-360 | |
| P577 | publication date | 2013-01-03 | |
| P1433 | published in | Surgery Today | Q15765823 |
| P1476 | title | Management of Barrett's esophageal carcinoma | |
| P478 | volume | 43 |
| Q37591969 | Barrett esophagus in Asia: same disease with different pattern |
| Q42425181 | Laparoscopic transhiatal approach for resection of an adenocarcinoma in long-segment Barrett's esophagus |
| Q39233917 | Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma |
| Q39550675 | Risk prediction in Barrett's esophagus - aspects of a combination of molecular and epidemiologic biomarkers reflecting alterations of the microenvironment |
| Q35133043 | The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma |
Search more.